Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Conditions: Multiple Sclerosis; Secondary-Progressive Multiple Sclerosis; Mesenchymal Stem Cells Interventions: Biological: Allogenic placenta derived mesenchymal stem cells Sponsors: Tehran University of Medical Sciences Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials